TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31479417

Group type: EXPERIMENTAL
Intervention: Eight-lncRNA signature
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Functional experiments with six out of the eight lncRNAs
Number of subjects: 343
Study: 28812398

Group type: EXPERIMENTAL
Intervention: Specific exercises
Number of subjects: 97

Group type: COMPARATOR
Intervention: Unspecific exercises
Number of subjects: 97
Study: 25792708

Group type: EXPERIMENTAL
Intervention: BET 2×1 mg/day (BET1, n=19)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: BET 2×2 mg/day (BET2, n=19)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: BVS 2×5 mL (0.4 mg/mL)/day (BVS, n=19)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (n=19)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: All budesonide groups (BET1, BET2, BVS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: BET1
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: All budesonide groups
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Effervescent tablet
Number of subjects: 76
Study: 24411508

Group type: EXPERIMENTAL
Intervention: DMIE intervention (personal navigators, enhanced medical care, and employment supports)
Number of subjects: 2279
Study: 20854449

Group type: EXPERIMENTAL
Intervention: Incredible Years parenting programme
Number of subjects: 46

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 46
Study: 18818905

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.5 mg/kg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 21
Study: 17379979

Group type: EXPERIMENTAL
Intervention: Off-pump surgery (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: On-pump surgery (Group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 15450781

Group type: EXPERIMENTAL
Intervention: Untreated bipolar patients
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lithium-treated patients
Number of subjects: 66
Study: 11931601

Group type: EXPERIMENTAL
Intervention: Metadate CD (methylphenidate HCI, USP) Extended‐Release Capsules sprinkled onto applesauce
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intact Metadate CD capsules
Number of subjects: 26
Study: 9807540

Group type: EXPERIMENTAL
Intervention: Written feedback and financial bonus (intervention group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study: 8720348

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 2565841

Group type: COMPARATOR
Intervention: Nifedipine plus placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine plus famotidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Famotidine alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 12
Study: 3093

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 6102231

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 30
Study: 30664512

Group type: EXPERIMENTAL
Intervention: Functional Action Observation (FAO) training
Number of subjects: 35

Group type: COMPARATOR
Intervention: General Action Observation (GAO) training
Number of subjects: 35
Study: 28645284

Group type: EXPERIMENTAL
Intervention: Indigenous individuals living in remote areas
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Participants aged over 65 years
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Lower baseline reported quality of life
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: History of diabetes
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: History of gout
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: History of chronic obstructive pulmonary disease
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Established CVD receiving guideline-recommended treatment prior to the trial
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Established CVD not receiving guideline-recommended treatment prior to the trial
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Morbidly obese patients
Number of subjects: 535
Study: 26455139

Group type: EXPERIMENTAL
Intervention: Clavicular hook plate combined with trapezius muscle fascia (experimental group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Clavicular hook plate (control group)
Number of subjects: 66
Study: 23689381

Group type: EXPERIMENTAL
Intervention: Fluid-restricted (maximum fluid intake, 800 mL/d) and sodium-restricted (maximum dietary intake, 800 mg/d) diet (Intervention Group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard hospital diet with liberal fluid and sodium intake (Control Group)
Number of subjects: 75
Study: 21493010

Group type: EXPERIMENTAL
Intervention: Clonidine (α2-adrenoceptor agonist, intravenous infusion)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19723122

Group type: EXPERIMENTAL
Intervention: Tonabersat 15 mg
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Tonabersat 40 mg
Number of subjects: 859

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 859
Study: 18165618

Group type: EXPERIMENTAL
Intervention: Proactive pegfilgrastim use
Number of subjects: 852

Group type: COMPARATOR
Intervention: Reactive pegfilgrastim use
Number of subjects: 852
Study: 15548438

Group type: EXPERIMENTAL
Intervention: Screened Group (SG)
Number of subjects: 9026

Group type: COMPARATOR
Intervention: Unscreened Group (UG)
Number of subjects: 9026
Study: 11898068

Group type: EXPERIMENTAL
Intervention: Gravity goniometer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pictures
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Standard goniometer
Number of subjects: 40
Study: 10475318

Group type: EXPERIMENTAL
Intervention: Intravenous dextromethorphan 5 mg/kg before anesthetic induction (Pre group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution followed by postoperative i.v. infusion of dextromethorphan 5 mg/kg (Post group)
Number of subjects: 60
Study: 7605941

Group type: EXPERIMENTAL
Intervention: Adenosine (50 micrograms kg‐1 min‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study: 2220663

Group type: EXPERIMENTAL
Intervention: Surgery and radiation therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 80
Study: 364517

Group type: EXPERIMENTAL
Intervention: alpha‐flupenthixol
Number of subjects: 38

Group type: COMPARATOR
Intervention: beta‐isomer of flupenthixol
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study: 31321677

Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 30
Study: 28074475

Group type: EXPERIMENTAL
Intervention: LPS injection (0.4 or 0.8 ng/kg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 24941951

Group type: EXPERIMENTAL
Intervention: Fiber-enriched orange juice (400 mL for 21 days)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo orange juice (400 mL for 21 days)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Fiber-enriched orange juice
Number of subjects: 192

Group type: COMPARATOR
Intervention: Both groups (fiber and placebo)
Number of subjects: 192
Study: 23053707

Group type: EXPERIMENTAL
Intervention: Minimally invasive nonsurgical technique (MINST)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical technique (MIST)
Number of subjects: 29
Study: 21663648

Group type: EXPERIMENTAL
Intervention: 45 g milk fat/d from test butter and cheese with 0.24 wt% phytanic acid
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control diet with 0.13 wt% phytanic acid
Number of subjects: 14
Study: 19562886

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 16728452

Group type: EXPERIMENTAL
Intervention: Gly16
Number of subjects: 31

Group type: COMPARATOR
Intervention: Arg16
Number of subjects: 31
Study: 14702229

Group type: EXPERIMENTAL
Intervention: four‐session cognitive‐behavioural intervention starting 5‐10 weeks after the injury
Number of subjects: 152

Group type: COMPARATOR
Intervention: no intervention
Number of subjects: 152
Study: 11978924

Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Flutter device
Number of subjects: 17
Study: 11477826

Group type: EXPERIMENTAL
Intervention: Radix Codonopsitis Pilosulae
Number of subjects: 103

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (non-HQD type)
Number of subjects: 103
Study: 9098299

Group type: EXPERIMENTAL
Intervention: Pressure patching
Number of subjects: 201

Group type: COMPARATOR
Intervention: No patching
Number of subjects: 201
Study: 2693116

Group type: EXPERIMENTAL
Intervention: Sublingual salbutamol tablet 2 mg (SL)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Swallowed tablet 2 mg (O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Metered dose inhaler 200 micrograms (MDI)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 7
Study: 370171

Group type: EXPERIMENTAL
Intervention: Intervention group (smoking cessation advice)
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1445
Study: 31685429

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (G1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (G2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 90
Study: 31350952

Group type: EXPERIMENTAL
Intervention: Home care using Eye Movement Desensitization and Reprocessing (EMDR) technique, 2 sessions (total of 60 sessions), each lasting 45 to 60 minutes.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 60
Study: 30078537

Group type: EXPERIMENTAL
Intervention: Phenylephrine 1.0%–ketorolac 0.3% injection
Number of subjects: 25

Group type: COMPARATOR
Intervention: Basic saline solution (Control)
Number of subjects: 25
Study: 26292645

Group type: EXPERIMENTAL
Intervention: Systemic oxygen therapy (10 L/min for 3 months)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Enalapril (5 mg daily for 3 months)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (for 3 months)
Number of subjects: 102
Study: 24356636

Group type: EXPERIMENTAL
Intervention: Dose-dense weekly paclitaxel and carboplatin (dd-TC)
Number of subjects: 637

Group type: COMPARATOR
Intervention: Conventional tri-weekly paclitaxel and carboplatin (c-TC)
Number of subjects: 637
Study: 22629129

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (Anesthesia Group, AG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (not anesthetized patients)
Number of subjects: 40
Study: 20080382

Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg, Caffeine 50 mg, Opium 25 mg
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg, Caffeine 50 mg, Opium 50 mg
Number of subjects: 232

Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 17396618

Group type: EXPERIMENTAL
Intervention: Pranlukast 450 mg daily
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fluticasone 200 microg daily
Number of subjects: 41
Study: 15378234

Group type: EXPERIMENTAL
Intervention: Permacol injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Macroplastique injection
Number of subjects: 50
Study: 12244504

Group type: EXPERIMENTAL
Intervention: EndoSheath group (disposable sheath system)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Standard colonoscope group (conventional video colonoscope)
Number of subjects: 226
Study: 10710824

Group type: EXPERIMENTAL
Intervention: New microemulsion formulation of cyclosporine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Marketed formulation of cyclosporine
Number of subjects: 18
Study: 7725883

Group type: EXPERIMENTAL
Intervention: Thigh tourniquet inflated after exanguination of the leg not being operated on
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no tourniquet)
Number of subjects: 40
Study: 1838749

Group type: EXPERIMENTAL
Intervention: OPC‐7251 1% cream
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cream base
Number of subjects: 28
Study: 7015173

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (LDH) injected subcutaneously in the contralateral thigh
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose heparin (LDH) injected subcutaneously in the contralateral abdominal skin-fold
Number of subjects: 0
Study: 29979275

Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 4 minutes recovery
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 12 minutes recovery
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 15 seconds recovery
Number of subjects: 29
Study: 31449568

Group type: COMPARATOR
Intervention: Suspended lunge
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bulgarian squat
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Suspended lunge-BOSU
Number of subjects: 20
Study: 28217880

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT) and treatment as usual (TAU)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT)
Number of subjects: 48
Study: 27290988

Group type: COMPARATOR
Intervention: Voluven (saline-based 6% hydroxyethyl starch 130/0.4)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tetraspan (balanced 6% hydroxyethyl starch 130/0.4)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Voluven and Tetraspan)
Number of subjects: 40
Study: 24524414

Group type: EXPERIMENTAL
Intervention: Ponto Pro
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: BP100
Number of subjects: 14

Group type: COMPARATOR
Intervention: Previous bone‐anchored hearing aids
Number of subjects: 14
Study: 22236064

Group type: EXPERIMENTAL
Intervention: Montessori-based activities conducted by family carers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control waiting list condition
Number of subjects: 0
Study: 19409578

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Very low energy diet (600-800 kcal/d)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combined analysis of both groups (Orlistat and Placebo)
Number of subjects: 68
Study: 17974365

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (UNIMMAP)
Number of subjects: 2550

Group type: COMPARATOR
Intervention: Iron/Folic Acid
Number of subjects: 2550
Study: 16271571

Group type: EXPERIMENTAL
Intervention: Ultrasonography for diagnosing congenital muscular torticollis (CMT)
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Predictive logistic regression model incorporating clinical correlates
Number of subjects: 1021
Study: 12549689

Group type: EXPERIMENTAL
Intervention: Ligasure system
Number of subjects: 112

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 112
Study: 9457811

Group type: EXPERIMENTAL
Intervention: brachytherapy + hyperthermia (HT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: brachytherapy (no heat)
Number of subjects: 112
Study: 7883848

Group type: EXPERIMENTAL
Intervention: 200 mg iodine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 400 mg iodine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 800 mg iodine
Number of subjects: 117
Study: 1453217

Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.8 g/(kg.d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.6 g/(kg.d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.4 g/(kg.d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egg protein at 0.6 g/(kg.d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egg protein at 0.45 g/(kg.d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egg protein at 0.3 g/(kg.d)
Number of subjects: 0
Study: 6366810

Group type: EXPERIMENTAL
Intervention: Sulfamethopyrazine (200 mg)/trimethoprim (250 mg) combination
Number of subjects: 72

Group type: COMPARATOR
Intervention: Co-trimoxazole (400 mg sulphamethoxazole plus 80 mg trimethoprim)
Number of subjects: 72
Study: 31375444

Group type: EXPERIMENTAL
Intervention: Lateralised tibial jig placement
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (mid-point of tibial plateau as reference)
Number of subjects: 216
Study: 30543642

Group type: EXPERIMENTAL
Intervention: Dilemma-focused intervention (DFI)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: CBT group + CBT individual
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: CBT group + DFI individual
Number of subjects: 128
Study: 26912543

Group type: EXPERIMENTAL
Intervention: Tolvaptan (45/15, 60/30, or 90/30 mg daily as tolerated)
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 1445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1445
Study: 25804839

Group type: EXPERIMENTAL
Intervention: R-MCP (rituximab plus mitoxantrone, chlorambucil, and prednisolone)
Number of subjects: 129

Group type: COMPARATOR
Intervention: MCP (mitoxantrone, chlorambucil, and prednisolone)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: R-MCP
Number of subjects: 129

Group type: COMPARATOR
Intervention: MCP
Number of subjects: 129
Study: 23601497

Group type: EXPERIMENTAL
Intervention: Succimer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 20646510

Group type: EXPERIMENTAL
Intervention: TRAE + cryoablation
Number of subjects: 77

Group type: COMPARATOR
Intervention: TRAE
Number of subjects: 77
Study: 17959591

Group type: EXPERIMENTAL
Intervention: TENS at the PC-5 and PC-6 points
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: TENS at non-acupoints of both shoulders
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study: 17022381

Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional stent implantation
Number of subjects: 50
Study: 14617323

Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of calcium-gluconate at a dose of 1.8 mmol calcium per hour
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of calcium-gluconate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Calcium-gluconate
Number of subjects: 50
Study: 11232756

Group type: EXPERIMENTAL
Intervention: Poor metabolic control (26 patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Well-controlled diabetic patients (18 patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy subjects (12 subjects)
Number of subjects: 44
Study: 9213104

Group type: EXPERIMENTAL
Intervention: Cisplatin-based neoadjuvant chemotherapy plus radiotherapy
Number of subjects: 161

Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Cervical nodal necrosis
Number of subjects: 161
Study: 8322240

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 20 cm H2O, PEEP 0 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 20 cm H2O, PEEP 5 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 10 cm H2O, PEEP 0 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 10 cm H2O, PEEP 5 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Addition of PEEP to both levels of PIP
Number of subjects: 9
Study: 3114302

Group type: EXPERIMENTAL
Intervention: Bromocriptine (BCT; 3.75 mg/day; n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 28
Study: 31565955

Group type: EXPERIMENTAL
Intervention: Project ImPACT for Toddlers
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 25
Study: 29172949

Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection (LLR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open liver resection (OLR)
Number of subjects: 50
Study: 26897592

Group type: EXPERIMENTAL
Intervention: Pain assessment and management algorithms (ALGs) with intensive training and support.
Number of subjects: 485

Group type: COMPARATOR
Intervention: Pain education (EDU) only.
Number of subjects: 485
Study: 25315205

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (nurse case-manager-based model)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Usual care control (nonscreened patients)
Number of subjects: 476
Study: 23019944

Group type: EXPERIMENTAL
Intervention: Maixuekang Capsule (MC), 12 capsules daily for 12 months
Number of subjects: 236

Group type: COMPARATOR
Intervention: Routine treatment (RTT)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Maixuekang Capsule (MC)
Number of subjects: 236
Study: 20573448

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block with perineural ropivacaine 0.2% for 4 days
Number of subjects: 77
Study: 18055726

Group type: EXPERIMENTAL
Intervention: Vitamin C (1,000 mg) and Vitamin E (400 International Units)
Number of subjects: 734

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Vitamin C and Vitamin E
Number of subjects: 734
Study: 16126331

Group type: EXPERIMENTAL
Intervention: SpeediCath
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: LoFric
Number of subjects: 49

Group type: COMPARATOR
Intervention: InCare Advance Plus (gel-lubricated uncoated catheter)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Hydrophilic catheters (SpeediCath and LoFric)
Number of subjects: 49